N@N

OmniComm Systems' TrialMaster(TM) EDC Solution Selected for Its Reputation for Meeting Aggressive Timelines

^{Published on 2009-12-15 06:08:53 - Market Wire}
 

FORT LAUDERDALE, FL--(Marketwire - December 15, 2009) - OmniComm Systems, Inc. (OTCBB: [ OMCM ]), one of the fastest growing companies in the EDC marketplace, today announced that a West Coast biopharmaceutical company, who specializes in small molecule medicines across a number of therapeutic areas, has selected OmniComm's TrialMaster EDC solution for conducting a Phase I study. The 9-month, 2-site study is planning to enroll over 80 subjects.

"We look forward to working on this Phase I study and we are pleased that OmniComm's eClinical solution, TrialMaster, was chosen by this sponsor," remarked Stephen Johnson, COO of OmniComm Systems. "Facing aggressive timelines, the Sponsor selected OmniComm based on its reputation for building studies quickly and staying within budget. Furthermore, it was important to the new client that OmniComm be able to support its internal data standards initiative." OmniComm's TrialMaster solution has supported the CDISC ODM, CDASH (including naming conventions and domain structures), HL7, E2B, and caBIG standards for years, and with the addition of CDISC SDTM, will be the first EDC Company to leverage all of the industry leading standards in a single solution.

About OmniComm

OmniComm Systems, Inc. ([ www.OmniComm.com ]) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small, to large-scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc has U.S. headquarters in Fort Lauderdale, FL and European headquarters in Bonn, Germany, with satellite offices in New Jersey and the United Kingdom, as well as sales offices throughout the U.S. and Europe.

Safe Harbor Disclaimer

Statements made by OmniComm included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.